ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This was a Phase 3, multi-center extension of Alkermes' Study ALK21-003EXT (NCT01218971) to
further assess the long-term safety of repeat monthly doses of Medisorb® naltrexone
(VIVITROL®).